SCHEMBL3410140

SCHEMBL3410140

CC(C)C(C(=O)N1CCC(c2ccccc2)(N(C)C)CC1)N(C)Cc1ccc2[nH]ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.42
CYP2D6 P10635 1/20 0.42
EPHX2 P34913 1/20 0.42
FAAH O00519 1/20 0.40
MAPK14 Q16539 2/20 0.40
NAMPT P43490 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SLC6A2 P23975 6/20 0.38
SLC6A4 P31645 6/20 0.38
SLC6A3 Q01959 6/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
OPRM1 P35372 3/20 0.37
OPRL1 P41146 3/20 0.37
CHRM2 P08172 1/20 0.36
CTNNB1 P35222 1/20 0.35
WNT3A P56704 1/20 0.35
AGTR2 P50052 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3404748 0.94 AGTR2 (0.41) EPHX1CYP2D6EPHX2FAAHMAPK14
SCHEMBL3405575 0.77 FAAH (0.38) EPHX1CYP2D6EPHX2FAAHMAPK14
SCHEMBL3404179 0.76 EPHX1 (0.46) EPHX1CYP2D6EPHX2FAAHMAPK14
SCHEMBL3434090 0.74 SIGMAR1 (0.41) EPHX1CYP2D6EPHX2FAAHSLC6A2
SCHEMBL3403070 0.72 KDM4E (0.48) FAAH
SCHEMBL3404182 0.72 OPRM1 (0.45) EPHX1CYP2D6EPHX2FAAHMAPK14
SCHEMBL4092689 0.72 FAAH (0.41) EPHX1CYP2D6EPHX2FAAHMAPK14
SCHEMBL3408086 0.71 FFAR2 (0.38) FAAHMAPK14OPRM1OPRL1AGTR2
SCHEMBL3408818 0.69 OPRM1 (0.44) EPHX1CYP2D6EPHX2FAAHMAPK14
SCHEMBL13735842 0.69 CCR1 (0.47) OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 EPHX1 2955/4885CYP2D6 57/4885EPHX2 3081/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 EPHX1 2955/4885CYP2D6 57/4885EPHX2 3081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.